Healthcare and Life Science articles
Partner, National Sector Leader, Healthcare , KPMG (US)
Blockchain could be a key to interoperability and privacy
November 12, 2018
Balancing opportunity and risk to bring your drug to this important market.
Reinvent innovation and become an R&D front-runner by 2030
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
Top 5 factors every biotech and pharmaceutical company should keep in mind
October 23, 2018
Unlocking value for life sciences organizations
This CIO Survey is the largest IT leadership study in the world, and summarizes what we learned about the transformational CIO.
October 19, 2018
Cost transformation today lays the groundwork for innovation tomorrow.
September 28, 2018
KPMG/RAPS survey illustrates the ground medical device companies still have to cover
Harvey Nash/KPMG CIO Survey 2018: Pharmaceuticals Industry Findings
July 25, 2018
Identifying opportunities for life sciences manufacturers.
2018 Program benchmark report
Driving value in healthcare
May 23, 2018
Innovation in the life sciences finance function
April 26, 2018
Finance disrupted - As the industry adjusts to continuous disruption, the finance function has an opportunity to lead
April 17, 2018
As new entrants and cross-sector models abound, which direction should healthcare organizations turn?
March 26, 2018
Aligning MACRA payment model development with CMMI priorities
March 09, 2018
March 05, 2018
Healthcare providers and payers need to up their IT game. The clock is ticking
February 26, 2018
As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical
February 24, 2018
New standard. New challenges.
February 23, 2018
The industry’s stance on the Cloud is transitioning from fear to optimism
February 22, 2018
Rethinking public private partnerships for universal healthcare